Holen Sie sich die Stockscreener-App
565.39
0.51%
-2.82
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$568.21
Offen:
$574
24-Stunden-Volumen:
761.65K
Relative Volume:
0.38
Marktkapitalisierung:
$212.41B
Einnahmen:
$43.74B
Nettoeinkommen (Verlust:
$6.58B
KGV:
32.67
EPS:
17.3072
Netto-Cashflow:
$6.11B
1W Leistung:
-2.59%
1M Leistung:
-1.24%
6M Leistung:
+38.38%
1J Leistung:
+5.23%
1-Tages-Spanne:
$564.64
$575.25
1-Wochen-Bereich:
$560.16
$588.11
52-Wochen-Spanne:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
565.35 | 213.48B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
224.35 | 158.56B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.27 | 56.43B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
141.14 | 40.32B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
220.34 | 38.07B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Q4 Earnings Estimate for TMO Issued By KeyCorp - MarketBeat
Natixis Has $23.43 Million Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Ossiam Sells 3,400 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Acquired by London & Capital Asset Management Ltd - MarketBeat
Goldman Sachs Initiates Coverage on Thermo Fisher Scientific (TM - GuruFocus
6,343 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by SVB Wealth LLC - MarketBeat
Fluorosilicic Acid Market Size, Forecast 2031 by Key Companies- - openPR.com
Microplate Systems Market Is Booming So Rapidly| Thermo Fisher Scientific; Danaher Corporation; Agilent Technologies Inc; PerkinElmer Inc - pharmiweb.com
gRNA Market Size Worth USD 3,171.65 Million By 2034 Fueled by Rapid Expansion of Gene Editing Applications - GlobeNewswire Inc.
Axa S.A. Lowers Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Goldman Sachs initiates Thermo Fisher Scientific stock with Buy rating - Investing.com
Goldman Sachs initiates Thermo Fisher Scientific stock with Buy rating By Investing.com - Investing.com UK
Thermo Fisher Scientific introduces the Thermo Scientific X and S Series Centrifuges - SelectScience
TMO Stock Quote Price and Forecast - CNN
Keybanc Upgrades Thermo Fisher Scientific (TMO) to 'Overweight' with Price Target of $750 | TMO Stock News - GuruFocus
Vega Investment Solutions Sells 11,414 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
WINTON GROUP Ltd Acquires Shares of 16,314 Thermo Fisher Scientific Inc. $TMO - MarketBeat
Temasek Holdings Private Ltd Trims Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Stockbridge Partners LLC Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
KeyBanc Upgrades Thermo Fisher Scientific to Overweight From Sector Weight, Price Target is $750 - marketscreener.com
Cerity Partners LLC Sells 2,142 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Baker Avenue Asset Management LP Boosts Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
KeyBanc upgrades Thermo Fisher Scientific stock rating to Overweight with $750 target - Investing.com India
Jump Financial LLC Purchases 38,298 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
California Public Employees Retirement System Decreases Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Cary Street Partners Financial LLC Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Brown Advisory Inc. Reduces Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Dnca Finance Has $8.49 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Bollard Group LLC Acquires 62,000 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Who Owns Thermo Fisher Scientific? Top Shareholders and Recent Insider Trades - TIKR.com
Thermo Fisher Scientific (NYSE:TMO) COO Sells 22,046 Shares - MarketBeat
Stenger Family Office LLC Makes New $1.01 Million Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Mirabella Financial Services LLP Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Epoch Investment Partners Inc. Sells 53,867 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Cresset Asset Management LLC Purchases 7,364 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific: Could Its New Sanofi Site Supercharge America’s Drug Supply Chain? - Smartkarma
Michel Lagarde Sells 32,000 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat
Insider Selling: Thermo Fisher Scientific (NYSE:TMO) COO Sells 30,000 Shares of Stock - MarketBeat
Lagarde of Thermo Fisher sells $12.4m in stock - Investing.com
Lagarde of Thermo Fisher sells $12.4m in stock By Investing.com - Investing.com UK
Will Thermo Fisher's Asia Bioprocessing Tri-Hub Expansion Reshape Thermo Fisher Scientific's (TMO) Narrative? - simplywall.st
Thermo Fisher Scientific expands bioprocessing capabilities in India, Korea and Singapore - chemengonline.com
Regional expansion to accelerate Asian biopharma growth - Labmate Online
Price Over Earnings Overview: Thermo Fisher Scientific - Benzinga
Knuff & Co LLC Sells 3,559 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stake Cut by Kennedy Capital Management LLC - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Baird Financial Group Inc. - MarketBeat
Amundi Lowers Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Can Thermo Fisher Scientific Inc. (TN8) stock sustain double digit ROE2025 AllTime Highs & Technical Analysis for Trade Confirmation - Newser
Thermo Fisher’s New Asia Bioprocessing Network Might Change The Case For Investing In Thermo Fisher Scientific (TMO) - Yahoo Finance
Thermo Fisher Scientific expands Bioprocess Design Centers to strengthen Asia’s biopharma manufacturing capacity - BioMelbourne Network
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):